• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home The Classics COVID-19 Classics

COVID-19 pneumonia patients in Wuhan, China [Classics Series]

byDeepti Shroff, DMD, MS
July 8, 2022
in COVID-19 Classics, The Classics
Reading Time: 2 mins read
Share on FacebookShare on TwitterShare on LinkedIn

This study summary is an excerpt from the book 2 Minute Medicine’s The Classics in Medicine: Summaries of the Landmark Trials

1. This case series of patients with novel coronavirus–infected pneumonia (NCIP) found that 32% were admitted to the intensive care unit (ICU) and 15% died.

2. A significant proportion of patients (29%) developed acute respiratory distress syndrome

Original Date of Publication: January 2020

Study Rundown: In this prospective case series, clinical features of NCIP patients in Wuhan, China were investigated during the beginning of the pandemic. The majority of patients were men without underlying chronic disease who had been exposed at the Huanan seafood market. The most common symptoms on initial presentation were fever, cough, myalgia, and fatigue. After admission, over half of patients developed lymphopenia and dyspnea. The present study was limited in that it evaluated a limited cohort of hospitalized patients. Thus, the findings cannot be extrapolated to the general population of COVID-19 patients. Additionally, only lower respiratory tract specimens were obtained to confirm diagnosis without information on viral load. In summary, COVID-19 infection may result in NCIP, severe respiratory distress, and subsequent ICU admission.

Click to read the study in The Lancet

EvidencePulse™by 2 Minute Medicine®

How does COVID-19 pneumonia patients in Wuhan, China apply to your patient?

Describe your patient and EvidencePulse weighs this trial against later evidence and current guidelines, with citations.

Ask EvidencePulse

For a fuller review of the evidence, Deep research is a core feature of 2MM Max.

FDA approvedFor COVID-19: Xocova (ensitrelvir), May 29, 2026→

In-Depth [prospective case-series]: This prospective case series evaluated the clinical presentation and course of NCIP inpatients (n = 41). Almost three quarters of participants were male (73%) with a median age of 49. Only 32% of patients had underlying chronic disease, the most common being diabetes (20%). The most common presenting complaints were fever (98%) and cough (76%). Dyspnea occurred in 55% of patients at a median time of 8 days after initial symptoms. Acute respiratory distress syndrome occurred in 29% of patients with 15% of patients being admitted to the ICU and a 15% mortality rate. During initial evaluation, significantly increased prothrombin time (p = 0.012) and D-dimer levels (p = 0.0042) were seen in patients who were admitted to the ICU. Most patients were treated with antiviral therapy (93%), and all patients initially received empirical antibiotic treatment. Additionally, 22% of patients received systemic corticosteroids.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet. 2020 Feb 15;395(10223):497-506.

Trials since this one

What later trials found on the same question.

  1. 2021

    Third dose of BNT162b2 COVID-19 vaccine effective at decreasing risk of hospitalization In The Classics

    Compared to two doses of the BNT162b2 vaccine, a third booster dose was estimated to be 93% effective against admission to hospital due to COVID-19 infection.

  2. 2021

    Inactivated whole-virion SARS-CoV-2 vaccine reduces rates of symptomatic COVID-19 infections In The Classics

    Incidence of PCR-confirmed symptomatic COVID-19 cases was lower in the vaccine group compared with the placebo group.

5 more since 2020

2MM+ See every trial since COVID-19 pneumonia patients in Wuhan, China

2MM+ shows the full timeline of later trials on this question, with what each one found, and lets you save trials to reading lists for rounds, journal club and boards.

See 2MM+ plans Sign in

Citation: Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/s0140-6736(20)30183-5. Epub 2020 Jan 24. PMID: 31986264; PMCID: PMC7159299.

© 2022 2 Minute Medicine, Inc. All rights reserved. No part of this article may be reproduced, distributed or transmitted in any form or by any means without the prior written permission of 2 Minute Medicine, Inc. To license this content, contact 2 Minute Medicine, Inc. This article is for informational and educational purposes only; it is not medical advice and does not replace the judgment of a qualified healthcare professional.
Image: © 2 Minute Medicine

Tags: #COVID-19 pneumoniaacute respiratory distress syndrome (ARDS)antibioticsantiviralsCoronavirusICU

New landmark trials, every weekday

The free 2 Minute Medicine Daily Brief: practice-changing studies summarized by physicians, in your inbox.

Your subscription opens securely in a new tab.

More COVID-19 Classics

Previous Post

#VisualAbstract: Restriction of Intravenous Fluids in ICU Patients with Septic Shock

Next Post

Regular physical activity associated with lower all-cause and cause-specific mortality compared with physical inactivity

Next Post
Exercise collage: a smiling older woman with silver hair beside a pair of hand weights, a jump rope and a folded towel

Regular physical activity associated with lower all-cause and cause-specific mortality compared with physical inactivity

BNT162b2 booster dose associated with reduced risk of SARS-CoV-2 infection and mortality among older adults in long-term care facilities

Thrombophilia-associated stillbirth risk appears limited to factor V Leiden

Prothrombin complex concentrate noninferior to plasma infusion for patients with post-cardiopulmonary bypass coagulopathy

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Thoracic epidural and paravertebral blockade have similar efficacy for reduction of chronic post-thoracotomy pain
  • Brepocitinib improved cutaneous sarcoidosis activity compared to placebo in phase II of BEACON trial.
  • In topline phase 3 results, dazodalibep reduced systemic disease activity in Sjögren’s disease
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.